Christopher Bunka

Insider Reports History

Entity
Individual
Location
1924 Birkdale Ave, Kelowna, British Columbia, Canada
Signature
/Chris Bunka/
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Bunka:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexaria Bioscience Corp. Director common shares 274K $676K $2.47 Jan 7, 2025 Direct
Lexaria Bioscience Corp. Director common shares 254K $629K $2.47 Jan 7, 2025 Private Holding Company
Lexaria Bioscience Corp. Director Restricted Stock Award 374K Jan 7, 2025 Direct
Lexaria Bioscience Corp. Director Stock Options 181K Apr 26, 2024 Direct
Lexaria Bioscience Corp. Director Stock Options 181K Jan 7, 2025 Direct
Lexaria Bioscience Corp. Director Warrants 6.67K Jan 7, 2025 Private Holding Company

Insider Reports Filed by Christopher Bunka

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LEXX Lexaria Bioscience Corp. Jan 7, 2025 1 $0 4 Jan 10, 2025 Director
LEXX Lexaria Bioscience Corp. Apr 26, 2024 1 $0 4 May 10, 2024 Chief Executive Officer, Director
LEXX Lexaria Bioscience Corp. Oct 26, 2023 1 $0 4 Oct 30, 2023 Chief Executive Officer, Director
LEXX Lexaria Bioscience Corp. Oct 12, 2022 2 $78.4K 4/A Oct 18, 2022 Chief Executive Officer, Director
LEXX Lexaria Bioscience Corp. Aug 29, 2022 1 $0 4 Aug 29, 2022 Chief Executive Officer, Director
LEXX Lexaria Bioscience Corp. Sep 1, 2021 1 $0 4 Sep 2, 2021 CEO, Director
LEXX Lexaria Bioscience Corp. Jun 8, 2021 1 $0 4 Jun 9, 2021 CEO, Director
LEXX Lexaria Bioscience Corp. May 7, 2021 1 $0 4 Jun 9, 2021 CEO, Director